Medical Reviews

The DIA-RAMADAN Study: Summary video, IDF symposium replay and Poster

Discover the real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN

The video above summarizes the DIA-RAMADAN study design, key results and conclusion regarding the use of gliclazide MR in fasting conditions.

This study plans to explore the real-world safety and effectiveness of gliclazide modified release (MR) in patients with type 2 diabetes mellitus (T2DM) fasting during Ramadan. It is a prospective, international, observational study conducted in nine countries.